- Home
- TCRX vs IROQ Comparison
TCRX vs IROQ Comparison
Compare TCRX & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- IROQ
- Stock Information
- Founded
- TCRX 2018
- IROQ 1883
- Country
- TCRX United States
- IROQ United States
- Employees
- TCRX N/A
- IROQ N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- IROQ Savings Institutions
- Sector
- TCRX Health Care
- IROQ Finance
- Exchange
- TCRX Nasdaq
- IROQ Nasdaq
- Market Cap
- TCRX 67.9M
- IROQ 75.8M
- IPO Year
- TCRX 2021
- IROQ 2011
- Fundamental
- Price
- TCRX $1.44
- IROQ N/A
- Analyst Decision
- TCRX Strong Buy
- IROQ
- Analyst Count
- TCRX 6
- IROQ 0
- Target Price
- TCRX $9.83
- IROQ N/A
- AVG Volume (30 Days)
- TCRX 520.8K
- IROQ 2.0K
- Earning Date
- TCRX 05-12-2025
- IROQ 04-29-2025
- Dividend Yield
- TCRX N/A
- IROQ 1.70%
- EPS Growth
- TCRX N/A
- IROQ 56.77
- EPS
- TCRX N/A
- IROQ 0.95
- Revenue
- TCRX $2,816,000.00
- IROQ $24,226,000.00
- Revenue This Year
- TCRX $47.30
- IROQ N/A
- Revenue Next Year
- TCRX $74.30
- IROQ N/A
- P/E Ratio
- TCRX N/A
- IROQ $24.76
- Revenue Growth
- TCRX N/A
- IROQ 8.37
- 52 Week Low
- TCRX $1.02
- IROQ $14.85
- 52 Week High
- TCRX $9.69
- IROQ $25.76
- Technical
- Relative Strength Index (RSI)
- TCRX 49.74
- IROQ 46.42
- Support Level
- TCRX $1.02
- IROQ $23.01
- Resistance Level
- TCRX $1.36
- IROQ $24.20
- Average True Range (ATR)
- TCRX 0.16
- IROQ 0.40
- MACD
- TCRX 0.05
- IROQ -0.06
- Stochastic Oscillator
- TCRX 77.78
- IROQ 21.34
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About IROQ IF Bancorp Inc.
IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.